ZINGIBERACEAE Zingiber officinale  Roscoe

 Synonym

    none ...
 Thai / English name

  • ขิง*

[4-9] of 9 article(s) found

 หน้า  1  2  

[4] CYTOCHROME P450 INHIBITORY POTENTIAL AND RP-HPLC STANDARDIZATION OF TRIKATU—A RASAYANA FROM INDIAN AYURVEDA.
RANJIT K. HARWANSH,KAKALI MUKHERJEE,SANTANU BHADRA,ET AL.
J ETHNOPHARMACOL 2014 Vol.153(),674-81  $51721 [Full]

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Trikatu laboratory formulation / DMSO
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 223.254+/-0.92 and 245.23+/-1.92 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

[5] INHIBITORY ACTIVITIES OF THAI MEDICINAL PLANTS WITH PROMISING ACTIVITIES AGAINST MALARIA AND CHOLANGIOCARCINOMA ON HUMAN CYTOCHROME P450.
WIRIYAPORN SUMSAKUL,WIRATCHANEE MAHAVORASIRIKUL,KESARA NA-BANGCHANG
PHYTOTHER RES 2015 Vol.29(),1926-33  $60695 [Full]

Part Used : เหง้า
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The selective inhibitor ketoconazole showed the most potent inhibitory activity on CYP3A4 with mean IC50 of 0.23 microgram/mL. PC, DM, DL, PI were most potent with mean IC 1.54-6.43 microgram/mL. PC exhibited similar inhibitory activity to ketoconazole (p > 0.05). GM and ZO exhibitied moderate potencies (mean IC50 11.33 and 11.58 microgram/mL, respectively). MF and AL exhibited relatively low potencies (mean IC50 41.91 and 54.36 microgram/mL, respectively) (substrate:nifedipine)
Note : Piper chaba (PC), Dioscroea membranacea (DI), Dracaenal oureiri (DG), Atractylodes lancea (AL), Plumbago indica (PI), Zingiber officinale (ZO), Myristica fragrans (MF), Garcinia mangostana (GM).

[6] THE INHIBITORY CONSTITUENTS FROM THE GINGER ON A DRUG METABOLIZING ENZYME CYP3A4.
CHA BC,LEE EH,KWON JT
YAKHAK HOECHI 2004 Vol.48(5),266-71  288187 [Abstract]

Part Used : เหง้า
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : 10-gingerol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The results showed 10-gingerol (IC50 5.75 microM) is isolated from EtOAc extract of ginger show remarkable inhibitory activity compared to 6-gingerol (IC50 14.56 microM) and zingerone (IC50 379.63 microM).
Note : Data incomplete

[7] GINGER FRACTION FOR INHIBITING HUMAN CYTOCHROME P 450 ENZYMES.
EBNER T,LUDWIG-SCHWELLINGER E,BLECH S,ET AL.
PCT INT APPL WO 2007071708 2007 Vol.(),38pp  358041 [Abstract]

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : -
Type of experiment : human
Type of animal : -
Type of study : non specified
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : Oral administration
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Ginger fraction, use thereof on its own or combined with drugs for inhibiting human cytochrome P450 (CYP) enzymes (particularly cytochrome P 450 3A4, CYP3A4) for positive influencing the oral bioavailablity and pharmacokinetics of active substance.
Note : Data incomplete from abstract

[8] METHOD FOR PRODUCING A GINGER FRACTION AND THE USE THEREOF FOR INHIBITING HUMAN CYP ENZYMES.
EBNER T,LUDWIG-SCHWELLINGER E,BLECH,ET AL.
PCT INT APPL WO 2006024414 2006 Vol.(),  400090 [Abstract]

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Ginger fraction
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : -
Remark :
Note : Data incomplete

[9] P02 INHIBITORY EFFECT AND MECHANISM-BASED INHIBITION OF THAI HERBAL PLANTS ON CYP3A4 AND CYP2D6 ACTIVITIES.
DUMRONGSAKUNCHAI W,ATTAKORNVATTANA V,SOMANABANDHU A,ET AL.
THAI J PHARMACOL 2007 Vol.29(1),35-9  416780 [Abstract]

Part Used : เหง้า
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The ethanolic extract of Zingiber officinale inhibited CYP3A4 activity with IC50 value 30.3+/-15.1 microgram/ml.
Note : Testosterone 6beta-hydroxylase and dextromethorphan O-demethylase were used as maker of CYP3A4 and CYP2D6 activity, respectively.

Part Used : เหง้า
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The aqueous extract of Zingiber officinale inhibited CYP3A4 activity with IC50 value 270+/-79.4 microgram/ml.
Note : Testosterone 6beta-hydroxylase and dextromethorphan O-demethylase were used as maker of CYP3A4 and CYP2D6 activity, respectively.


 หน้า  1  2